Table: Kyorin Pharmaceutical -Q1 group results

Kyorin Pharmaceutical

02/08/2023 07:00

Aug 2 (Reuters)- 
             Kyorin Pharmaceutical Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.85               24.62           116.20    
                 (+13.1 pct)         (-0.3 pct)       (+2.6 pct)  
  Operating        710 mln             489 mln            6.00    
                 (+45.1 pct)                          (+17.1 pct) 
  Recurring        913 mln             779 mln            6.50    
                 (+17.2 pct)                          (+11.5 pct) 
  Net              676 mln               1.18             4.90    
                 (-42.8 pct)                          (+3.7 pct)  
  EPS             11.81 yen           20.65 yen        85.51 yen  
  Ann Div                             52.00 yen        52.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             32.00 yen        32.00 yen  
  
  NOTE - Kyorin Pharmaceutical Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4569.T